Literature DB >> 25883717

Prevalence of human T-cell leukemia virus type 1 carrier in Japanese pregnant women in 2013.

Shunji Suzuki1, Masanobu Tanaka1, Hideo Matsuda1, Yuki Tsukahara1, Yasushi Kuribayashi1, Akihito Nakai1, Ryoichiro Miyazaki1, Naoki Kamiya1, Akihiko Sekizawa1, Nobuko Mizutani1, Katsuyuki Kinoshita1.   

Abstract

Entities:  

Year:  2015        PMID: 25883717      PMCID: PMC4394927          DOI: 10.14740/jocmr2097w

Source DB:  PubMed          Journal:  J Clin Med Res        ISSN: 1918-3003


× No keyword cloud information.

To the Editor

Since September 2010, in Japan serological screening for the detection of human T-cell leukemia virus type 1 (HTLV-1) antibodies can be performed for all women during pregnancy with the Japanese public funds for strategies for prevention of HTLV-1 vertical transmission, because Japan, especially Kyushu area, has been reported to be one of the areas of highest prevalence of HTLV-1 in the world [1, 2]. In our previous study [3], we examined the prevalence of HTLV-1 carrier in Japanese pregnant women according to the implement rate and results of HTLV-1 screening and confirmation tests of women who gave births in Japan in 2011. The total rates of positive HTLV-1 screening tests and positive western blot (WB) test in positive screening tests were 0.32% and 49.8%, respectively in 2011. Considering the response rate and the rate of implementation of WB test, the number of HTLV-1 carrier in Japanese pregnant women in 2011 was estimated to be 1,560 (0.15%). In addition, although the number of delivery in Kyushu area was only 14% of Japanese deliveries, 53% of HTLV-1 carrier of Japanese pregnant women was present in Kyushu area. Recently, the migration of Japanese people from Kyushu area to the metropolitan areas has been thought to contribute to a significant decrease of HTLV-1 carriers in Kyushu area and an increase in Kanto (including Tokyo) area in Japan [1, 4]. To confirm this migration in Japanese pregnant women, on December 2014, we requested again 2,544 obstetrical facilities that are members of Japan Association of Obstetricians and Gynecologists (JAOG) to provide information of HTLV-1 tests in pregnant women who delivered at ≥ 22 weeks’ gestation in 2013. A total of 1,356 (53.3%) of 2,544 obstetrical facilities responded and information on a total of 538,167 women, accounting for approximately 54% of all deliveries that occurred in Japan during the study period (approximately 1,001,800 births) was provided. In 2013, the total rates of positive HTLV-1 screening tests and positive WB test in positive screening tests were 0.35% and 50.8%, respectively. Considering the response rate and the rate of implementation of WB test, the number of HTLV-1 carrier in Japanese pregnant women in 2013 was estimated to be 1,780 (0.18%). Table 1 shows the difference in the estimated number of HTLV-1 carrier based on positive WB test by area in Japan between 2011 and 2013. The estimated number of HTLV-1 carrier in 2013 seemed to be more than that in 2011, especially in the northeast and southwest (Kyushu) areas. In addition, 51% of HTLV-1 carrier of Japanese pregnant women was present in Kyushu area, although the number of delivery in Kyushu area was only 13% of Japanese deliveries in 2013.
Table 1

Results of HTLV-1 Western Blot Tests and Estimated Number of Human T-Cell Leukemia Virus Type 1 Carrier in Pregnant Women Who Delivered at ≥ 22 Weeks’ Gestation in 2011 and 2013 by Area in Japan

2011
2013
WB positive rate (%)Estimated HTLV-1 carrierWB positive rate (%)Estimated HTLV-1 carrier
Northeast area0.084900.140150
Kanto (around Tokyo)0.0622300.067240
Central area0.0831200.080110
Kinki (around Osaka)0.1512400.163270
West central area0.1131100.104100
Kyushu area (southwest area)0.5968200.663910
Total0.1541,5600.1781,780

Values are presented as percentage or number. HTLV-1: human T-cell leukemia virus type 1; WB test: western blot test.

Values are presented as percentage or number. HTLV-1: human T-cell leukemia virus type 1; WB test: western blot test. Although the migration of Japanese people from Kyushu area to the metropolitan areas has been supposed to contribute to a significant decrease of HTLV-1 carriers in Kyushu area, the estimated number of HTLV-1 carrier of pregnant women seemed to be increased in Kyushu area. In addition, the estimated rate of HTLV-1 carrier in pregnant women in Kyushu area was still significantly higher than that in the other areas (P < 0.01 by the Chi-square test). Therefore, there are still remaining problems concerning the locality for strategies for prevention of HTLV-1 vertical transmission in Japan.
  4 in total

Review 1.  HTLV infection and its implication in gynaecology and obstetrics.

Authors:  Ioannis Mylonas; Ansgar Brüning; Franz Kainer; Klaus Friese
Journal:  Arch Gynecol Obstet       Date:  2010-06-22       Impact factor: 2.344

2.  Current status of HTLV-1 carrier in Japanese pregnant women.

Authors:  Shunji Suzuki; Masanobu Tanaka; Hideo Matsuda; Yuki Tsukahara; Yasushi Kuribayashi; Hideto Gomibuchi; Ryoichiro Miyazaki; Naoki Kamiya; Akihito Nakai; Katsuyuki Kinoshita
Journal:  J Matern Fetal Neonatal Med       Date:  2013-07-09

3.  Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.

Authors:  Masahiro Satake; Kazunari Yamaguchi; Kenji Tadokoro
Journal:  J Med Virol       Date:  2012-02       Impact factor: 2.327

Review 4.  Current status of HTLV-1 infection.

Authors:  Toshiki Watanabe
Journal:  Int J Hematol       Date:  2011-10-04       Impact factor: 2.319

  4 in total
  3 in total

Review 1.  Human T-cell leukemia virus-associated malignancy.

Authors:  Amanda R Panfil; Michael P Martinez; Lee Ratner; Patrick L Green
Journal:  Curr Opin Virol       Date:  2016-08-31       Impact factor: 7.090

2.  Prevalence of human T-lymphotropic virus type 1 and 2 (HTLV-1/-2) infection in pregnant women in Brazil: a systematic review and meta-analysis.

Authors:  Bruna Angelo Vieira; Augusto Bacelo Bidinotto; William Jones Dartora; Luana Giongo Pedrotti; Vanessa Martins de Oliveira; Eliana Márcia Wendland
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

Review 3.  Human T-Cell Leukemia Virus Type 1 Envelope Protein: Post-Entry Roles in Viral Pathogenesis.

Authors:  Victoria Maksimova; Amanda R Panfil
Journal:  Viruses       Date:  2022-01-13       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.